Spatial Multi-Omics Integration with Mass Spectrometry Imaging: Decoding Metabolic Landscapes and Disease Mechanisms
Computational and Structural Biotechnology Journal · 01.03.2026 · 35 (1)
DOI: 10.34133/csbj.0257 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Computational and Structural Biotechnology Journal, online erschienen am 12.11.2026. Verfasst von Xiaorui Bu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Die Arbeit nennt 159 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Spatial multi-omics links molecular measurements to tissue architecture, but integrating spatial transcriptomics with mass spectrometry imaging (MSI) remains challenging because the modalities differ in sampling unit, spatial resolution, data structure, and molecular-identification certainty. This review synthesizes the enabling technologies and presents an evidence-calibrated workflow spanning tissue acquisition, spatial registration, modality-specific preprocessing, cross-modal annotation, mechanistic modeling, and orthogonal validation. We examine how MSI can complement single-cell and spatial transcriptomic or proteomic measurements in studies of tumor–host interfaces, metabolic dysfunction-associated steatotic liver disease, adipose-tissue organization, and decidualization at the maternal–fetal interface. Across these applications, spatial colocalization is most informative when annotation confidence is reported and key chemical identities are validated, registration error is quantified, and candidate cell–metabolite relationships are tested by isotope tracing or perturbation. We further discuss molecular ambiguity, resolution–sensitivity–throughput trade-offs, 3-dimensional reconstruction, interlaboratory reproducibility, and requirements for clinical translation. The central conclusion is that spatial multi-omics is best used to formulate anatomically explicit, falsifiable hypotheses rather than to infer causality from aligned maps alone.
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
ORCID-Profile: Xiaorui Bu
Förderung
- Natural Science Foundation of Hubei Province
Zitieren
APA
Bu, X., & Wang, L. (2026). Spatial Multi-Omics Integration with Mass Spectrometry Imaging: Decoding Metabolic Landscapes and Disease Mechanisms. Computational and Structural Biotechnology Journal, 35(1). https://doi.org/10.34133/csbj.0257
Vancouver
Bu X, Wang L. Spatial Multi-Omics Integration with Mass Spectrometry Imaging: Decoding Metabolic Landscapes and Disease Mechanisms. Computational and Structural Biotechnology Journal. 2026;35(1). doi:10.34133/csbj.0257
BibTeX
@article{Bu2026,
author = {Bu, Xiaorui and Wang, Lufang},
title = {Spatial Multi-Omics Integration with Mass Spectrometry Imaging: Decoding Metabolic Landscapes and Disease Mechanisms},
journal = {Computational and Structural Biotechnology Journal},
year = {2026},
volume = {35},
number = {1},
doi = {10.34133/csbj.0257}
}
EUVIMED